2026 NPPES data Hematology & Oncology Physician NPI 1699768374 M.D.
Verify on CMS →

NASSER JANBAY, M.D.

Hematology & Oncology Physician in OKLAHOMA CITY, Oklahoma. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
157
Medicare Part D claims · 129 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
15%
generic claims · 85% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
96.6069/100
▲ 14 pts above national avg 83.1 · [object Object]
What the federal data reveals: NASSER JANBAY, M.D. is a Hematology & Oncology Physician ([object Object]) practicing in OKLAHOMA CITY, Oklahoma with a Medicare Part D prescribing footprint of 157 claims across 129 beneficiaries — 85% brand-name prescribing . Their CMS MIPS Final Score of 96.6069/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities .

What stands out: NASSER JANBAY, M.D. reported a CMS MIPS final score of 96.6069 out of 100, above the 83.1 national average, and filed 157 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

NASSER JANBAY, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

NASSER JANBAY, M.D. at a glance

High performer (top quartile)

NPI registry status

Active

Issued 08/26/2005

NPI 1699768374

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

157 81% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

96.6069/100 13.506900000000002% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Oklahoma

How Hematology & Oncology Physician compares to other specialties among Oklahoma providers

Oklahoma providers

Hematology & Oncology Physician share within Oklahoma

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Oklahoma

Medicare quality performance — MIPS

NASSER JANBAY, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
96.6069/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 96.6069/100 vs national avg 83.1

0%100%National avg83%96.6%
MIPS final score (Hematology & Oncology Physician) — 96.6069/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NASSER JANBAY, M.D. is a Hematology & Oncology Physician provider practicing in OKLAHOMA CITY, Oklahoma, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1699768374. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

NASSER JANBAY, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 4301 S WESTERN AVE, OKLAHOMA CITY, OK, 73109, with a listed phone of (405) 631-0919. NPI 1699768374 was issued on 08/26/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what JANBAY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 157 prescription claims written by this provider, covering 129 Medicare beneficiaries and totaling roughly $41K in drug spend, split 85% brand-name and 15% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 96.6069/100 for the 2023 performance year (Quality 92.2415), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4301 S WESTERN AVE
OKLAHOMA CITY, OK 73109

Provider Details

NPI 1699768374
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 08/26/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

96.6069
Final Score
Avg: 83.1
92.2415
Quality
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where NASSER JANBAY, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MERCY CLINIC OKLAHOMA COMMUNITIES
ADA, OK

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Brand-heavy

NASSER JANBAY, M.D. — brand share 85.0%
Specialty average (est.)

85% brand-name claims vs 15% generic, on 157 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

157
Total Claims
$41K
Total Drug Cost
129
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
170
Total Day Supply
1,132
Brand vs Generic
85% brand / 15% generic
Brand Drug Cost
$40K
Generic Drug Cost
$953

Patient Demographics

Average Patient Age
76.0 years
Avg HCC Risk Score
0.99
Gender Split
59% female / 41% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Arexvy
Rsvpref3 Antigen/As01e/Pf
99
Shingrix
Varicella-Zoster Ge/As01b/Pf
26

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How NASSER JANBAY, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

NASSER JANBAY, M.D.'s 157 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Oklahoma

Other clinicians with the same primary specialty enrolled in Oklahoma, drawn from the same CMS NPPES roster as JANBAY.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NASSER JANBAY, M.D.'s specialty?
NASSER JANBAY, M.D. specializes in Hematology & Oncology Physician and practices in OKLAHOMA CITY, Oklahoma. Credentials: M.D..
How much does NASSER JANBAY, M.D. prescribe under Medicare Part D?
In 2023, NASSER JANBAY, M.D. wrote 157 Medicare Part D claims totaling $41K in drug costs for 129 beneficiaries.
What is NASSER JANBAY, M.D.'s Medicare quality score?
NASSER JANBAY, M.D. has a CMS MIPS Final Score of 96.6069/100 (Quality: 92.2415). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is NASSER JANBAY, M.D. located?
NASSER JANBAY, M.D. is located at 4301 S WESTERN AVE, OKLAHOMA CITY, OK, 73109. Phone: (405) 631-0919.
What is NASSER JANBAY, M.D.'s NPI number?
NASSER JANBAY, M.D.'s National Provider Identifier (NPI) is 1699768374, issued on 08/26/2005.
Does NASSER JANBAY, M.D. prescribe more brand-name or generic drugs?
NASSER JANBAY, M.D.'s prescribing is 85% brand-name and 15% generic drugs by claim count, with $40K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does NASSER JANBAY, M.D. prescribe most often?
Based on 2023 Medicare Part D data, NASSER JANBAY, M.D.'s most frequently prescribed drugs include Arexvy, Shingrix. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NASSER JANBAY, M.D. accept Medicare?
NASSER JANBAY, M.D. appears in CMS Medicare data with 157 Part D claims and 129 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NASSER JANBAY, M.D.'s credentials?
NASSER JANBAY, M.D.'s NPI is 1699768374 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology